USPIO增强MRI对头颈癌淋巴结分期的高准确性:基于淋巴结逐一对匹组织病理学的新阅片算法
本研究对10例头颈癌患者行体内USPIO增强MRI后行颈淋巴结清扫,并将离体标本MRI与组织病理学精确配准,建立淋巴结逐一对匹。在34枚可配对的淋巴结中,转移淋巴结在T2*加权MGRE序列上信号强度等于或高于脂肪组织(15/16,94%),而良性淋巴结信号低于脂肪(17/19,89%)或信号完全衰减(273/279,98%)。作者据此提出新的阅片算法,并指出下一步需在前瞻性、更大样本的临床研究中验证。
要点
- USPIO增强MRI上,转移淋巴结在T2*加权MGRE序列信号等于或高于脂肪组织(94%),良性淋巴结信号低于脂肪(89%)或完全衰减(98%)。
- 全组切除标本共检出392枚淋巴结,体内MRI漏诊6枚含(微)转移的淋巴结,是否与良性淋巴结配对或未被检出尚不明确。
- 作者基于高分辨率T2*加权USPIO增强MRI表现提出鉴别良恶性淋巴结的新阅片算法。
核心结论
- 作者基于高分辨率T2*加权USPIO增强MRI上淋巴结的表现,建立了鉴别头颈癌患者良恶性淋巴结的新阅片算法。
研究设计与样本
- 10例头颈癌患者在颈淋巴结清扫术前接受体内USPIO增强MRI,并行离体颈清扫标本MRI以实现体内MRI与组织病理学的精确配准;对体内MRI信号提示可能转移的淋巴结在常规组织病理学流程基础上进行细致逐一对匹。
关键影像表现/征象
- 转移淋巴结在T2*加权MGRE序列上信号强度等于或高于脂肪组织(15/16枚,94%)。
- 良性淋巴结在T2*加权MGRE序列上信号强度低于脂肪组织(17/19枚,89%)或信号完全衰减(273/279枚,98%)。
- 全组切除标本组织病理学共检出392枚淋巴结,体内MRI漏诊6枚含(微)转移的淋巴结。
诊断标准与关键数值
- 以组织病理学为参考,T2*加权MGRE序列上淋巴结信号等于或高于脂肪组织提示转移(15/16枚,94%)。
- 以组织病理学为参考,T2*加权MGRE序列上淋巴结信号低于脂肪组织(17/19枚,89%)或信号完全衰减(273/279枚,98%)提示良性。
局限性
- 6枚含(微)转移的淋巴结被体内MRI漏诊,这些淋巴结在体内MRI上是否与良性淋巴结配对或完全未被检出尚不明确。
- 作者指出下一步需在前瞻性临床研究中、以更大样本量验证该阅片算法,以进一步提高USPIO增强MRI颈淋巴结分期的准确性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Ultrasmall superparamagnetic iron oxide (USPIO)-enhanced magnetic resonance imaging (MRI) is a potential diagnostic tool for lymph node assessment in patients with head and neck cancer. Validation by radiologic-pathologic correlation is essential before the method is evaluated in clinical studies. In this study, MRI signal intensity patterns of lymph nodes are correlated to their histopathology to develop a new USPIO-enhanced MRI reading algorithm that can be used for nodal assessment in head and neck cancer patients.
MATERIALS AND METHODS: Ten head and neck cancer patients underwent in vivo USPIO-enhanced MRI before neck dissection. An ex vivo MRI of the neck dissection specimen was performed for precise coregistration of in vivo MRI with histopathology. Normal clinical histopathological workup was extended with meticulous matching of all lymph nodes regarded as potentially metastatic based on their in vivo MRI signal intensity pattern. On the basis of histopathology of resected nodes, in vivo MRI signal characteristics were defined separating benign from malignant lymph nodes.
RESULTS: Fifteen of 34 node-to-node correlated lymph nodes with remaining signal intensity on T2*-weighted MRI were histopathologically metastatic and 19 were benign. Radiological analysis revealed that metastatic lymph nodes showed equal or higher MRI signal intensity when compared with lipid tissue on T2*-weighted MGRE sequence (15/16 lymph nodes; 94%), whereas healthy lymph nodes showed lower (17/19 lymph nodes; 89%) or complete attenuation of signal intensity (273/279; 98%) when compared with lipid tissue on T2*-weighted MGRE. Histopathology of all resected specimens identified 392 lymph nodes. Six lymph nodes with (micro)metastases were missed with in vivo MRI. Whether these 6 lymph nodes were correlated to a nonmalignant lymph node on in vivo MRI or could not be detected at all is unclear.
CONCLUSIONS: We developed a new reading algorithm to differentiate benign from malignant lymph nodes in head and neck cancer patients on the basis of their appearance on high-resolution T2*-weighted USPIO-enhanced MRI. Next steps involve validation of our reading algorithm to further improve the accuracy of neck lymph node staging with USPIO-enhanced MRI in prospective clinical studies with larger number of patients.
引用
- Driessen, Zámecnik, Dijkema, et al. High-Accuracy Nodal Staging of Head and Neck Cancer With USPIO-Enhanced MRI: A New Reading Algorithm Based on Node-to-Node Matched Histopathology. Invest Radiol. 2022. PMID: 35776432. doi:10.1097/RLI.0000000000000902
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。